ELMD logo

Electromed, Inc. Stock Price

NYSEAM:ELMD Community·US$209.3m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author

ELMD Share Price Performance

US$25.91
-3.88 (-13.02%)
US$35.25
Fair Value
US$25.91
-3.88 (-13.02%)
26.5% undervalued intrinsic discount
US$35.25
Fair Value
Price US$25.91
AnalystConsensusTarget US$35.25
AnalystHighTarget US$38.00
AnalystLowTarget US$29.00

ELMD Community Narratives

AnalystConsensusTarget·
Fair Value US$35.25 26.5% undervalued intrinsic discount

Bronchiectasis Awareness And Home Care Will Drive Lasting Success

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystHighTarget·
Fair Value US$38 31.8% undervalued intrinsic discount

Rising Home Healthcare Trends Will Unlock New Market Opportunity

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value US$29 10.7% undervalued intrinsic discount

Concentrated Respiratory Care Will Face Hurdles While Sustaining Modest Promise

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$29
10.7% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
8.32% p.a.
Profit Margin
11.99%
Future PE
30.75x
Share price in 2028
US$35.23

Updated Narratives

ELMD logo

Bronchiectasis Awareness And Home Care Will Drive Lasting Success

Fair Value: US$35.25 26.5% undervalued intrinsic discount
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ELMD logo

Concentrated Respiratory Care Will Face Hurdles While Sustaining Modest Promise

Fair Value: US$29 10.7% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ELMD logo

Rising Home Healthcare Trends Will Unlock New Market Opportunity

Fair Value: US$38 31.8% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
4 Rewards

Electromed, Inc. Key Details

US$66.2m

Revenue

US$14.5m

Cost of Revenue

US$51.7m

Gross Profit

US$43.5m

Other Expenses

US$8.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.98
78.04%
12.38%
0%
View Full Analysis

About ELMD

Founded
1992
Employees
179
CEO
James Cunniff
WebsiteView website
smartvest.com

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Recent ELMD News & Updates

Recent updates

No updates